PO: Treatment of chronic myelogenous leukemia (CML) and bone marrow disorders.
IV: With cyclophosphamide as a conditioning regimen before allogenic hematopoietic progenitor cell transplantation for CML.
busulfan is a sample topic found inNursing Central.To find other Nursing Central topicsplease login or purchase a subscription.